Total Payments
$134,259
2023 Payments
$72,705
Companies
36
Transactions
617
Medicare Patients
1,314
Medicare Billing
$297,811
Payment Breakdown by Category
Other$96,860 (72.1%)
Travel$22,682 (16.9%)
Food & Beverage$11,079 (8.3%)
Consulting$3,520 (2.6%)
Education$116.69 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $96,860 | 23 | 72.1% |
| Travel and Lodging | $22,682 | 38 | 16.9% |
| Food and Beverage | $11,079 | 552 | 8.3% |
| Consulting Fee | $3,520 | 2 | 2.6% |
| Education | $116.69 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $102,488 | 75 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $21,470 | 20 | $0 (2023) |
| ABBVIE INC. | $2,200 | 132 | $0 (2023) |
| PFIZER INC. | $1,003 | 64 | $0 (2022) |
| Micro-tech Endoscopy USA, Inc. | $900.00 | 1 | $0 (2020) |
| IRONWOOD PHARMACEUTICALS, INC | $831.65 | 6 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $689.71 | 48 | $0 (2022) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $627.88 | 38 | $0 (2022) |
| Daiichi Sankyo Inc. | $391.78 | 23 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $361.94 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $72,705 | 63 | GENZYME CORPORATION ($58,282) |
| 2022 | $52,974 | 113 | GENZYME CORPORATION ($44,206) |
| 2021 | $1,322 | 63 | AbbVie Inc. ($392.37) |
| 2020 | $1,656 | 36 | Micro-tech Endoscopy USA, Inc. ($900.00) |
| 2019 | $1,807 | 119 | AbbVie, Inc. ($501.11) |
| 2018 | $2,551 | 137 | Ironwood Pharmaceuticals, Inc ($790.14) |
| 2017 | $1,244 | 86 | Valeant Pharmaceuticals North America LLC ($286.52) |
All Payment Transactions
617 individual payment records from CMS Open Payments — Page 1 of 25
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,149.00 | General |
| Category: Immunology | ||||||
| 11/30/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $124.53 | General |
| Category: IMMUNOLOGY | ||||||
| 11/09/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,763.00 | General |
| Category: Immunology | ||||||
| 11/09/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $752.10 | General |
| Category: Immunology | ||||||
| 11/09/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $251.36 | General |
| Category: Immunology | ||||||
| 11/09/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $243.67 | General |
| Category: Immunology | ||||||
| 11/09/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $101.52 | General |
| Category: Immunology | ||||||
| 11/09/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | Cash or cash equivalent | $77.62 | General |
| Category: Immunology | ||||||
| 11/09/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $58.52 | General |
| Category: Immunology | ||||||
| 11/09/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $9.83 | General |
| Category: Immunology | ||||||
| 11/08/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,447.00 | General |
| Category: Immunology | ||||||
| 11/08/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $752.11 | General |
| Category: Immunology | ||||||
| 11/08/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $292.17 | General |
| Category: Immunology | ||||||
| 11/08/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $251.36 | General |
| Category: Immunology | ||||||
| 11/08/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $127.38 | General |
| Category: Immunology | ||||||
| 10/11/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,605.00 | General |
| Category: Immunology | ||||||
| 10/11/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $109.05 | General |
| Category: Immunology | ||||||
| 10/11/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $100.87 | General |
| Category: Immunology | ||||||
| 09/29/2023 | GENZYME CORPORATION | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,224.00 | General |
| 09/29/2023 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $2,855.03 | General |
| 09/28/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,526.00 | General |
| Category: Immunology | ||||||
| 09/28/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $2,859.54 | General |
| Category: Immunology | ||||||
| 09/28/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $139.98 | General |
| Category: Immunology | ||||||
| 08/17/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,447.00 | General |
| Category: Immunology | ||||||
| 08/17/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $896.52 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 12 | 357 | 379 | $376,679 | $40,775 |
| 2021 | 15 | 407 | 2,071 | $715,290 | $98,725 |
| 2020 | 16 | 550 | 3,082 | $1.1M | $158,310 |
Total Patients
1,314
Total Services
5,532
Medicare Billing
$297,811
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 75 | 75 | $123,750 | $14,331 | 11.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 64 | 64 | $90,432 | $5,056 | 5.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 25 | 25 | $29,850 | $4,176 | 14.0% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2022 | 27 | 27 | $35,505 | $3,784 | 10.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 31 | $6,603 | $2,865 | 43.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 48 | 48 | $54,336 | $2,808 | 5.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 17 | 30 | $10,650 | $2,737 | 25.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $6,560 | $1,959 | 29.9% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 12 | 12 | $13,608 | $1,233 | 9.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 13 | 13 | $2,769 | $958.07 | 34.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 15 | $2,160 | $858.07 | 39.7% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2022 | 11 | 19 | $456.00 | $9.92 | 2.2% |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | Office | 2021 | 11 | 1,630 | $341,000 | $55,134 | 16.2% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 73 | 73 | $120,450 | $14,517 | 12.1% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 36 | 36 | $47,340 | $5,170 | 10.9% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 64 | 64 | $90,432 | $4,379 | 4.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 37 | 38 | $8,094 | $3,680 | 45.5% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 18 | 37 | $13,135 | $3,531 | 26.9% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 43 | 44 | $49,808 | $3,295 | 6.6% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2021 | 13 | 13 | $15,522 | $2,400 | 15.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $6,232 | $2,233 | 35.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 20 | 20 | $4,260 | $1,600 | 37.6% |
| 43248 | Insertion of guide wire with dilation of esophagus using an endoscope | Facility | 2021 | 13 | 13 | $14,742 | $1,521 | 10.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 11 | 11 | $935.00 | $622.62 | 66.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 13 | 13 | $1,872 | $505.26 | 27.0% |
About Dr. Subhash Gumber, MD
Dr. Subhash Gumber, MD is a Gastroenterology healthcare provider based in Cary, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1205975398.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Subhash Gumber, MD has received a total of $134,259 in payments from pharmaceutical and medical device companies, with $72,705 received in 2023. These payments were reported across 617 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($96,860).
As a Medicare-enrolled provider, Gumber has provided services to 1,314 Medicare beneficiaries, totaling 5,532 services with total Medicare billing of $297,811. Data is available for 3 years (2020–2022), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Cary, NC
- Active Since 02/05/2007
- Last Updated 11/22/2011
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1205975398
Products in Payments
- DUPIXENT (Biological) $117,803
- STELARA (Biological) $660.89
- XELJANZ (Drug) $520.80
- ZEPOSIA (Drug) $467.41
- INFLECTRA (Biological) $460.23
- HUMIRA (Biological) $415.80
- XIFAXAN (Drug) $390.71
- INJECTAFER (Drug) $359.89
- Entyvio (Biological) $341.08
- SKYRIZI (Biological) $339.59
- Creon (Drug) $296.77
- Humira (Biological) $291.68
- Cimzia (Drug) $282.20
- LINZESS (Drug) $270.38
- XIFAXANIBSD (Drug) $265.90
- ENTYVIO (Biological) $236.86
- CREON (Drug) $204.80
- Mavyret (Drug) $197.43
- Trulance (Drug) $186.13
- ZENPEP (Drug) $182.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Cary
Christopher Mcgowan
Gastroenterology — Payments: $67,271
Gastroenterology $67,271
Dr. Indira Reddy, M.d, M.D
Gastroenterology — Payments: $14,083
Gastroenterology $14,083
Mr. Rajendraprasad Makam, Md, MD
Gastroenterology — Payments: $6,816
Gastroenterology $6,816
Stephen Furs, M.d, M.D
Gastroenterology — Payments: $5,866
Gastroenterology $5,866
Mr. Zachary Spiritos, M.d., M.p.h, M.D., M.P.H
Gastroenterology — Payments: $4,915
Gastroenterology $4,915
Jeevan Pai, Md, MD
Gastroenterology — Payments: $4,067
Gastroenterology $4,067